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Abstract
A Gram negative species of bacteria, Campylobacter jejuni, is the leading cause of food
poisoning worldwide. Humans often contract food poisoning after ingesting contaminated
poultry. Detecting the presence of C. jejuni in poultry is difficult because it is part of the natural
flora and does not cause symptomatic infection. In a related manner, Bordetella avium is a Gram
negative species of bacteria that causes bordetellosis in poultry. This disease is similar to
whooping cough caused by the related pathogen of humans, B. pertussis. Though the mortality
rate for bordetellosis is low, it weakens the birds’ immune systems, often leading to secondary
infections. The aim of this project was to construct a vaccine platform capable of immunizing
poultry against both pathogens—B. avium and C. jejuni—thus reducing disease in birds and
humans. A heterologous construct can be made utilizing the B. avium autotransporter Baa1 that
plays a role in host cell attachment. Autotransporters are comprised of three genetic regions:
promoters to drive expression, and encoded passenger and transporter domains. The transporter
is a beta barrel anchored in the outer membrane. The passenger domain is translocated through
the transporter and secreted to the outer surface of the bacterial cell. An antigenic Campylobacter
gene was cloned into the encoded passenger domain of the Baa1 autotransporter in the context of
a suicide plasmid. Tri-parental mating was done to promote homologous recombination of the
construct into the B. avium chromosome. After concluding the construct was not in the
chromosome most likely due to instability, a plasmid was synthesized and the codons of the
Campylobacter region were optimized. Tri-parental mating was completed again. All steps were
verified with PCR and gel electrophoresis. A B. avium transconjugant containing the chimeric
cja::baa1 construct was isolated. Future work will involve gene expression and challenge
studies.
5

Introduction
Though not frequently known as a major concern of human health, Campylobacter jejuni
is a Gram negative bacterial species that is the leading cause of gastroenteritis worldwide (1). In
1996, C. jejuni was detected in stool samples at a higher rate than notorious food-borne disease
agents, Salmonella and Shigella combined (1). It is also more prevalent than E. coli O157: H7
(1). Although there are fourteen different species of Campylobacter, 99% of human infections
are caused by C. jejuni. Symptoms of gastrointestinal illness caused by C. jejuni include
diarrhea, fever, and abdominal cramps. The spread of this disease in humans is mainly through
contaminated poultry. In the USA, Europe, and Australia, 50%-70% of all Campylobacter
infections have been attributed to consumption of chicken (1). This food-borne pathogen is of
great concern, especially in the poultry industry.
Another bacterial species of concern in the poultry industry is Bordetella avium. B avium
is a Gram negative bacterium that causes bordetellosis in turkeys. Bordetellosis is similar to
whooping cough in humans, which is caused by another Bordetella species—B. pertussis (2). B.
avium colonizes many bird species, including commercially grown and wild birds (3), but only
causes disease in commercially grown turkeys (2). It is naturally avirulent in chickens, but can
still colonize them (2). The mortality rate for the disease in turkeys is low, however, bordetellosis
results in the weakening of many young turkeys’ immune systems thus allowing opportunistic
pathogens to infect the birds. Collectively, this causes several million dollars in losses to the U.S.
turkey industry each year (2). Furthermore, bordetellosis also impairs the growth of turkeys,
adding to the financial loss that the industry suffers (2). Since B. avium is found in poultry and
because there is currently no effective treatment nor effective vaccine for bordetellosis, it is a
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particularly pressing issue in the local economy in which the largest poultry industry in the
nation is located.
Though seemingly disconnected issues, C. jejuni and B. avium are related because they
are both found in poultry. Though one pathogen infects humans and one infects poultry, a
vaccine can be made to immunize against both utilizing the B. avium cellular machinery. A new
or improved vaccine against C. jejuni to protect human health is needed. Utilizing the
colonization capabilities of B. avium to ciliated cells in poultry (described in more detail below),
a dual vaccine platform is proposed that will combat both B. avium and C. jejuni. This duel
vaccine would primarily aim to protect against C. jejuni infections in humans and B. avium in
poultry. Preventing economic loss to the poultry industry would be an indirect positive outcome.
B. avium (as well as all infectious Bordetella species) has a preference for attaching to the
ciliated cells of its host (4). B. avium attaches to turkey tracheal epithelial cells (2). The
autotransporter, Baa1, is thought to play a role in B. avium attachment and virulence (5). In many
Gram negative species, autotransporters make up the largest protein family (6). They are usually
comprised of a C-terminal beta-barrel-shaped transporter domain anchored in the outer
membrane and an N-terminal passenger domain that crosses the outer membrane through the
beta barrel to be exposed on the cell surface. The autotransporter Baa 1 is considered a virulence
factor with the passenger domain contributing to the virulence of the pathogen, though
autotransporters may serve other purposes. Some examples autotransporter-mediated virulence
mechanisms include protein/ lipid degradation, serum resistance, and host cell attachment (5).
While N-terminal passenger domains are similar in structure between different bacterial species,
their functions vary greatly. The C terminal beta-barrel domain is a highly conserved structure
for transport across the membrane but can vary greatly in the sequence (6).
7

Stockwell et. al. (2011) provided a functional analysis of the first putative B. avium
autotransporter, Baa1. The baa1 sequence was predicted utilizing bioinformatics; a 48%
similarity at the amino acid level was seen between Baa1 and the known E.coli tissue adhesion
autotransporter, AIDA-I (7). Due to the similarity of Baa1 to AIDA-1, it was hypothesized that
Baa1 is involved in B. avium host cell attachment. To test this hypothesis, a knockout mutant
was created (i.e., ∆baa1). Loss of the baa1 gene resulted in a decrease of attachment to turkey
tracheal cells (8). The mean percentage of attachment of wild type cells was 5.17% whereas the
mean of the knockout mutant was 0.89% (8). This significant difference in attachment signified
that Baa1 plays a role in B. avium attachment to turkey tracheal cells (8).
The Baa1 autotransporter in B. avium is a good candidate for a heterologous vaccine
combating B. avium and C. jejuni because the mutant still attaches to the host, but is less virulent
than the wild type (5). If an antigenic Campylobacter region is substituted for the wild type
passenger domain, the C. jejuni protein will be secreted to the surface of the cell via the B. avium
transporter domain. This chimera will plausibly result in the recognition of both bacterial cells by
the turkey host’s immune system thus effectively immunizing against C. jejuni and B. avium.
The method and location of host cell attachment of B. avium in poultry validates the suitability of
a potential live vaccine.
In this work, a heterologous vaccine was built by using molecular techniques to make a
construct containing a C. jejuni gene in the passenger domain in place of the wild type B. avium
passenger domain. FlaA and CjaA were two C. jejuni antigenic proteins that were used to
replace the Baa1 passenger domain. FlaA is a flagellar protein and CjaA is an outer membrane
protein (9). The known antigenicity of these proteins increase the likelihood that the host turkey
will recognize and produce protective antibodies for C. jejuni. Steps in developing this platform
8

included constructing the Baa1 autotransporter to contain the foreign gene of interest (i.e., CjaA
or FlaA) in the passenger domain on a B. avium suicide plasmid, and then transferring the
construct from the E. coli suicide plasmid into the chromosome of B. avium by means of triparental mating. Allelic exchange was then confirmed. Expression, attachment, and in vivo
challenge studies will be done as a continuation of this work.
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Materials and Methods
Construction of the baa1::cjaA and baa1::flaA Suicide Plasmids
Plasmid DNA Extraction
Qiagen QuickLyse MiniPrep kit (Valencia, CA) was used to extract plasmids containing
cjaA and flaA (unpublished, Temple, L.M.). Bacterial suspensions of each E. coli strain
containing the aforementioned plasmids were made by swabbing colonies from a plate into 2 mL
of sterile water. Using materials from the kit, cells from 1.5 mL of suspension were pelleted by
centrifugation then resuspended in 400 µL of ice cold lysis solution. The lysate was incubated at
room temperature for 3 minutes then transferred to a column, and centrifuged for 1 minute at
13,000 rpm. Next, 400 µL QLW buffer was added and centrifuged again. The spin column was
transferred to a new microcentrifuge tube and 50 µL of the provided elution buffer was added to
the column and centrifuged for 1 minute to release the plasmid DNA. The preparation was
analyzed by gel electrophoresis and Nanodrop.
Restriction Enzyme Digest of the B154 Backbone and PCR of the C. jejuni Inserts
A double digest of plasmid B154 (containing the promoter and transporter regions
consecutively) was performed. The digest contained the following: 110 µL mini prep B154
plasmid DNA, 1.5 µL AgeI enzyme, and 12 µL NE Buffer I. The digest was incubated at 37°C
overnight and confirmed by gel electrophoresis. Next, 1.5 µL of the NruI enzyme and 13 µL of
NE Buffer 3 were added to the previous digest of AgeI. The digest was incubated at 37°C
overnight and confirmed by gel electrophoresis.
The cjaA and flaA inserts were amplified from their respective plasmids to isolate them
using Polymerase Chain Reaction (PCR). The total volume of the reaction was19 µL and
consisted of 10 µL of GoTaq Green polymerase, 8 µL dH2O, 0.5 µL forward primer, 0.5 µL
10

reverse primer, and a colony of the E. coli with the respective C. jejuni inserts. The samples were
run at the following settings: 1 cycle of 95°C for 2 minutes, 95°C for 15 seconds, 30 cycles of
47°C for 1 minutes, 68°C for 1 minute, and 1 cycle of 68°C for 5 minutes.
DNA Ligation and Transformation
The double-digested B154 plasmid containing the promoter and transporter regions was
ligated with the PCR products of flaA or cjaA using the Quick Ligation™ kit (Valencia, CA)
(Figure 1). The ligation mixture for cjaA was: 2µL concentrated plasmid, 8µL PCR product of
double-digested cjaA, 10µL 2X Quick Ligation Buffer, and 1µL T4 DNA Ligase. The ligation
mixture for flaA was: 5µL concentrated plasmid, 5µL PCR product of double digested flaA,
10µL 2X Quick Ligation Buffer, and 1µL T4 DNA Ligase. The tubes were mixed thoroughly
and centrifuged briefly before incubating at room temperature for 20-30 minutes and then stored
in the freezer.
T7 Express competent E. coli cells (NEB, Ipswich, MA) were thawed on ice for 10
minutes. Next, 5µL of each ligation mix was added to separate tubes and put on ice for 30
minutes. The tubes were heat shocked at 42°C for exactly 10 seconds and then immediately
transferred to ice for five minutes. Next, 950µL room temperature SOC was pipetted into each
tube and then the tubes were placed in the 37°C shaker for 60 minutes. Meanwhile, ampicillin
selection plates (100 µg/mL) were warmed in the 37°C incubator. After shaking, the tubes were
mixed by flicking and inverting. Then, 250µL of the transformed cells were spread on one plate.
The remaining cell/ligation mixture was spread on another
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Figure 1. Plasmid Construct of Chimeric baa1 containing flaA/ cjaA in the Passenger
Domain. The flaA region was inserted into the wild type passenger domain using AgeI sites. A
similar plasmid—containing the cjaA region—was also made. The flaA/ cjaA regions were
inserted in the B154 backbone.
Polymerase Chain Reaction
Putative baa1::cjaA and baa1::flaA clones were amplified using Polymerase Chain
Reaction (PCR) to confirm the presence of the flaA and cjaA genes. The reaction mixture had a
total volume of 19 µL and consisted of 10µL of GoTaq Green polymerase, 8 µL dH2O (with the
exception of the positive control which had 7 µL), 0.5 µL forward primer, 0.5 µL reverse primer,
and a colony of the transformed E. coli with the respective plasmid transformed into it. The
positive control contained 1µL of the respective flaA/ cjaA DNA from the plasmid that the
inserts were originally amplified from. The samples were run at the following settings: 1 cycle of
12

95°C for 2 minutes, 95°C for 15 seconds, 30 cycles of 47°C for 1 minutes, 68°C for 1 minute,
and 1 cycle of 68°C for 5 minutes.
Putative transconjugants in B. avium were amplified using PCR to confirm the presence
of the flaA and cjaA genes. The reaction mixture had a total volume of 20 µL and consisted of 10
µL of KOD Master Mix (Sigma-Aldrich, St. Louis, MO), 7 µL dH2O (with the exception of the
negative control which had 8 µL), 0.5µL forward primer, 0.5µL reverse primer, and 1 µL of 40
ng/µL extracted chromosomal DNA from the putative transconjugants. The positive control
contained 1µL of the plasmid DNA. The samples were run using the same thermocyles as
described above. The only changes were the annealing temperatures (which were dependent
upon the primers used; see results) and the temperature of extension (70°C).
Gel Electrophoresis
PCR products were observed using gel electrophoresis. One percent agarose gels were
made using 0.5 g agarose, 50mL 1X TAE buffer, and one microliter of 10mg/mL ethidium
bromide. A 1 kb ladder (NEB, Ipswich, MA) was used as the standard. The gels were run at 110
volts/400 amps for approximately 40 minutes. Gels were imaged on a Bio-Rad ChemiDoc MP
imager.
Movement of baa1::flaA/ baa1::cjaA Construct into the B. avium Chromosome
Tri-Parental Mating
The positive baa1::flaA and baa1::cjaA E. coli clones were mated with B. avium 197N
(10) with the help of E. coli/pRK2013 (11) to facilitate homologous recombination (12). A
bacterial suspension of each strain was made by swabbing colonies from a plate into 3mL of LB
broth. All suspensions were normalized to and optical density (OD) at 600nm of 1.0 (12). Next,
400µL of the B. avium suspension was mixed with 50µL of the E. coli (pRK2013) (11)
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suspension and 50µL of the E. coli flaA or cjaA suspensions in a microcentrifuge tube. Five
hundred microliters of each mating mixture was plated on a thin LB plate to provide absorption
and allow for close contact. The plated mixtures were incubated at 37°C for 6-8 hours. Then, the
mating mixtures were transferred to the selection plates (150µg/mL kanamycin, 30µg/mL
naladixic acid, 100µg/ mL ampicillin) using cotton swabs in a single primary streak. Negative
controls were mock mating mixtures, containing the recombinant E. coli clones, E.coli/pRK2013
(11), and B. avium 197N. The selection plates were incubated for 24 hours, after which the
secondary and tertiary streaks were completed and incubated at 37°C for 48 hours. If single
colonies were observed, DNA was extracted from each clone by the DNeasy kit (Quiagen,
Valencia, CA). When using the synthesized plasmid clone in the tri-parental mating, only
kanamycin and naladixic acid (not ampicillin) were used as selective agents.
The resulting colonies were patched on plates containing kanamycin as the selectable
marker. The constant antibiotic pressure insured stability of the integrated plasmid. PCR was
used to screen the putative transconjugants for the foreign Campylobacter region after passaging
on kanamycin plates. Once verified, the kanamycin selection was removed and the putative
transconjugants were passaged in LB broth to encourage a second crossover event. One colony
was inoculated into 2 mL LB Broth. A dilution series of the passaged clones was made and 100
µL of the 10-6, 10-7, and 10-8 dilutions were plated to obtain individual colonies. Chromosomal
DNA was extracted from each colony and the second homologous crossover was verified by
PCR.
DNA Extraction of B. avium
The Qiagen DNeasy Blood and Tissue kit (Valencia, CA) was used to extract
chromosomal DNA from B. avium. One milliliter of B. avium grown in broth overnight was
14

centrifuged for one minute at 14,000 rpm and the supernatant was removed. The pellet was
resuspended in 200µL PBS. Next, 20µL proteinase K was added and incubated at 37°C for 15
minutes. Then, 200µL Buffer AL was added. After vortexing, the mixture was incubated at 56°C
for 10 minutes immediately followed by the addition of 200µL of 100% ethanol. After
transferring the mixture to a mini spin column, the column was centrifuged at 8,000 rpm for one
minute. Next, 500µL Buffer AW2 was added and the column was centrifuged at 14,000 rpm for
three minutes. The DNA was eluted with 100µL of hot distilled water and incubated at room
temperature for 1 minute. The column was centrifuged for one minute at 8,000 rpm. The released
and captured DNA was saved; the concentration of which was measured by Nanodrop.
Construct Synthesis and Codon Optimization
The inability to isolate stable single crossover clones of B. avium carrying the
recombinant flaA or cjaA plasmid led to the decision to have the construct synthesized by
Invitrogen (Carlsbad, CA). The cjaA gene was used as the foreign antigen insert between the
promoter and transporter regions of baa1 (Figure 2) because the cjaA gene was shorter and
therefore cheaper to have synthesized. The GC content of the synthesized cjaA coding region
was optimized that match that of B. avium; C. jejuni has a 35% GC content whereas B. avium is
61% GC. The program used for this optimization was http://genomes.urv.es/OPTIMIZER/. A
kanamycin resistance gene was also engineered into this plasmid as a selectable marker.
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Figure 2. Map of the Synthesized Plasmid Containing the GC-Optimized cjaA Region. The
synthesized plasmid was 3855 bp long, with a 1577 bp long baa1::cjaA region.
Primer Design
Primers were made to amplify a region of the newly synthesized construct using the
computer program SnapGene (Table 1). One primer pair was selected to flank the promoter/
transporter regions and another was made to flank the cjaA region. They were all designed to be
around 20 base pairs long, with annealing temperature close to 65°C (Table 1). Similar
annealing temperatures allows for amplification using different combinations of primers. These
primers were used to verify first and second homologous recombination crossover events
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Table 1. Primers for the Synthesized Plasmid used in Verification of Homologous
Recombination
Primer
Annealing Fragment
Sequence (5’ to3’)
Temperature
Length
Combination
(°C)
(bp)
ProCjaTra-F

TAGGCCTCTATGCGACGCGC

ProCjaTra-R

AGCAGGCGGTACTCGTAAGGC

CjaO-F

TCACCATCATCATGCGGCAGCG

ProCjaTra-R

AGCAGGCGGTACTCGTAAGGC

68

1519

69

1215

Colony Morphology Study
An investigation of the colony morphology (i.e., size) of the transconjugants was done by
passaging them on different media: kanamycin/ naladixic acid, kanamycin, LB, and TSA plates.
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Results
The initial goal was to produce a plasmid containing the baa1 promoter and transporterencoding region fused to a portion of cjaA or flaA (Figure 1). PCR was utilized to amplify the C.
jejuni genes. The amplified PCR products were ligated with the double digested B154 (AgeI and
NruI) plasmid backbone and transformed into E. coli. Successful ligation/transformation was
verified by growth on ampicillin selection plates and colony PCR of the cjaA and flaA regions
(Figure 3). Clones CjaA-10 and CjaA-13 tested positive for the recombinant plasmid (Figure 3).
One clone, FlaA-14, was positive for the recombinant plasmid.
1kb ladder (+)

(-)

8

9

10

11

12

13

14

Figure 3. Confirmation of the Ligation and Tranformation of cjaA and flaA into pB154. Gel
electrophoresis showing the cjaA and flaA genes were successfully ligated in between the
promoter and transporter region of Baa1 in the E. coli vector B154. The gel of samples to test
the cjaA-containing clones is on the left; flaA-containing samples were assessed in the gel on the
right. The arrows indicate the positive control bands of cjaA (~800 bp) and flaA (~900 bp). The
sample bands (lanes 10 and 13 (left) and 14 (right)) were the correct size.
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The successfully transformed E. coli strains were propagated using LB plates containing
ampicillin. Glycerol stocks were made for long-term storage. Next, a tri-parental mating was
performed with one of the transformed E. coli strains for each Campylobacter insert: CjaA-13
and FlaA-14. Many colonies grew on the kan/amp/nal selection plates (Figure 4). Chromosomal
DNA was extracted from colonies on the tri-parental mating selection plates. Using the same
flaA/ cjaA primers used to verify the E.coli transformation, single crossovers events into B.
avium 197N were assessed via PCR. Neither the cjaA nor the flaA regions were present in the
putative transconjugants. Different combinations of primers, different annealing temperatures,
and different DNA polymerases were used to verify the first crossover—with no success. During
this PCR optimization process, only nonspecific products were observed. In other cases, no
bands were observed in association with the isolated B. avium transconjugants (Figure S1). A
purified recombinant plasmid (pB154(cjaA) or pB154(flaA))was used as the positive controls in
all experiments and yielded visible bands at their respective locations each time.

Figure 4. Tri Parental Mating Selection Plates. Resulting growth after the tri-parental mating
with the ligated plasmid, B. avium 197N, and pRK2013. The negative control plate testing the
three strains individually is on the left, the cjaA mating is in the center, and the flaA mating is on
the right. Note the numerous individual colonies on both the cjaA and flaA plates. It is atypical
to obtain so many putative transconjugants following a mating procedure.
PCR was done on the putative transconjugants to amplify the promoter region of the baa1
gene. This was done to ascertain the quality of our purified chromosomal DNA. That is, if it
was possible to amplify sequences found in wild type B. avium. The purified recombinant
19

plasmids were used as positive controls. All putative transconjugants showed a band at the
expected size: ~250 base pairs (Figure 5).

Figure 5. Verification of Amplifiable Regions in the Putative Transconjugants. Gel
electrophoresis showing that the baa1 promoter region (251 bp) of the B. avium chromosome
were amplifiable in clones F1, F2, C1, and C2.
With the results that the cjaA and flaA regions were not amplifiable (Figure S1), but other
regions (such as the promoter region and the kanamycin resistance gene) (Figure S2) were, we
concluded that the Campylobacter genes were unstable in a B. avium background due to
incompatibility of GC content. As a result, we decided to abandon the manual cloning method in
lieu of purchasing a synthesized version of the desired plasmid. In this version of the cjaA
construct, we optimized the cjaA encoding fragment to better match the GC content of B. avium
(61%). Only one plasmid was synthesized and it contained the optimized cjaA gene in between
the promoter and transporter region of baa1 (Figure 2) because the cjaA gene was shorter than
flA and therefore cheaper to have synthesized. The purchased plasmid contained a kanamycin
resistance gene as a selectable marker.
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The newly synthesized plasmid was transformed into E. coli and recombinant clones
were confirmed by PCR. Another tri-parental mating was done utilizing E. coli containing the
synthesized plasmid, pRK2103 (11), and B. avium 197N. These mating plates looked more
typical of tri-parental mating plates, with fewer colonies forming in the first quadrant (Figure 6).
These colonies were passaged on kan plates initially. Chromosomal DNA was extracted and
PCR was done utilizing the new primers that were designed (Table S1) to verify that the
construct had crossed over into the chromosome during the tri-parental mating.

Figure 6. Tri-Parental Mating Selection Plate with Synthesized Plasmid. This LB plate
contained kanamycin and naladixic acid to select for the putative B. avium transconjugants and
displays a typical number of colonies arising from a tri-parental mating.
Different combinations of the ProCjaTra-F, ProCjaTra-R, CjaO-F, and CjaO-R primers
were used to verify the first crossover event into B. avium; a temperature gradient was used to
assess which annealing temperature yielded the most robust singular bands. The ProCjaTraF/ProCjaTra-R primer set was a pair that gave the properly sized band on the gel (1,519 base
pairs) (Figure 7). Another band around the same intensity appeared below the band of interest at
21

just over 1,000 base pairs. This is believed to be the amplicon of the wild type copy of baa1 that
would also appear in the transconjugants after the first crossover occurs Annealing temperatures
over 60°C gave more distinct, but less intense banding patterns whereas annealing temperatures
under 60°C gave less distinct but higher intensity bands. When using this primer set again, 60°C
was chosen as the annealing temperature.

Figure 7. Verification of the First Crossover using a Temperature Gradient PCR. Gel
electrophoresis of a temperature gradient PCR reaction on the chromosome of one sample
(called BPCT-1)of the putative transconjugants to verify the first crossover. The annealing
temperature ranged from 55°C to 68°C (indicated above each lane). ProCjaTra-F and
ProCjaTra-R primers were used. The arrow on the left is indicating the positive control band
and the arrow on the right is indicating the band of interest.
The CjaO-F/ ProCjaTra-R primer combination also resulted in the expected band size of
1,215 base pairs (Figure 8), with the addition of another smaller intensity band immediately
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beneath it, just above the 1,000 base pair marker. Future reactions with this primer set used 65°C
as the chosen annealing temperature.

Figure 8. Verification of the First Crossover using a Temperature Gradient PCR Using CjaOF and ProCjaTra-R Primer Combination. Gel electrophoresis of a temperature gradient PCR
reaction on the chromosome of one sample (BPCT-1)of the putative transconjugants to verify the
first crossover. The annealing temperature ranged from 55°C to 68°C. CjaO-F and ProCjaTra-R
primers were used. The arrow on the left is indicating the positive control band and the arrow on
the right is indicating the band of interest.
These results indicated that the first crossover event was successful, and we had
recombinant B. avium transconjugant. Next, kanamycin was removed from the media to allow
the loss of the plasmid backbone from the chromosome. Unusual colony morphologies were
observed during this passaging process. Interestingly, these morphologies were not when the
transconjugants were under kanamycin selection (Figure 9). When under selection, the colonies
23

were opaque, mucosal, and punctiform. After taking the selection away, a mixed morphology
arose (Figure 9). Colonies were still opaque and mucosal, but some colonies were bigger and
some remained punctiform.

Figure 9. Flow Chart Diagram and Results of Mixed Colony morphology study. A flow chart
that indicates the passaging of colonies from one plate to another, the type of media they were
transferred to, and the resulting colony sizes. The green plate indicates the selection plate that
the tri-parental mating was plated on. The blue plates indicate growth of punctiform colonies.
Purple plates indicate larger colonies.
24

Kanamycin selection was removed and two B. avium clones were serially passaged in LB
broth. Cultures were diluted and plated to obtain isolated colonies. Of these two separate plates
containing isolated colonies, chromosomal DNA was extracted from five colonies from each
plate. The CjaO-F/ ProCjaTra-R primer pair was used in a PCR reaction to validate the second
crossover, and thus the completion of homologous recombination. The positive control displayed
a correct band size of 1,215 base pairs (Figure 10). Other nonspecific bands were present in the
positive control. All samples with the exception of sample 2-13 displayed a prominent band at
the expected size—approximately 2,000 base pairs. Sample 2-13 displayed a prominent band at
approximately 1,200 base pairs (Figure 10). All samples displayed multiple nonspecific bands.

Figure 10. Verification of the Second Crossover on Ten Different Passaged B. avium
Transconjugants. PCR was done on chromosomal DNA to verify the second crossover event,
resulting in the loss of the wild type copy. The annealing temperature was 65°C and CjaO-F and
ProCjaTra-R primers were used. The green arrows indicate the positive control band at 1215 bp
(left) and successful transconjugant (center). The purple arrow (right) indicates a nonspecific
band and therefore an unsuccessful transconjugant.
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A follow-up PCR reaction was completed to reduce the nonspecific bands by using a
higher annealing temperature. Both CjaO-F/ ProCjaTra-R and ProCjaTra-F/ ProCjaTra-R
primers were used. The ProCjaTra-F/ ProCjaTra-R primer set used a 68°C annealing temperature
whereas the CjaO-F/ ProCjaTra-R primers used a 69°C annealing temperature. Random bands
were visible for 1-15 using the ProCjaTra-F/ProCjaTra-R primer set. Also, a band mirroring the
positive control at 1,500 base pairs was visible in 2-13 (Figure 11). However, the intensity was
weak and there were still other nonspecific bands. When using the CjaO-F/ ProCjaTra-R
primers, no bands were visible in the 1-15 sample indicating the cjaA gene was not present in
that sample’s chromosome. This confirmed 1-15 was a negative transconjugant, but still showed
the possibility of 2-13 being a true transconjugant because the largest and brightest band matched
the positive control at approximately 1,200 base pairs.

Figure 11. Verification of Recombinant B. avium clones containing the baa1::cjaA construct.
Gel electrophoresis of a PCR reaction on the samples 1-15 and 2-13 using ProCjaTra-F and
ProCjaTra-R primers at 68°C and CjaO-F and ProCjaTra-R primers at 69°C. The mint green
arrows indicate the positive control band at 1215 bp (left) and successful transconjugant 2-13
(right).
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Discussion
This purpose of this project was to construct a recombinant B. avium strain that could be
used as a heterologous vaccine platform to combat the causative agent of food poisoning, C.
jejuni, and simultaneously immunize against the causative agent of bordetellosis in turkeys, B.
avium. This vaccine could be administered to turkeys to combat bordetellosis and reduce
Campylobacter contamination of poultry products. Doing so would indirectly reduce human
food poisoning. Making a vaccine that combined would immunize against a human pathogen and
an avian pathogen would give turkey farmers an economic incentive to actively advocate for this
vaccine. All parties benefit, including turkey farmers, the poultry, and the consumers. This
vaccine could relieve multiple related illnesses.
Though initially expression of the construct via plasmid was the ideal, getting the
construct into a plasmid that replicated in B. avium proved problematic. Tri-parental matings
with a recombinant suicide plasmid had to be done to deliver the baa1-cjaA construct into the
chromosome to produce a stable chimera. This was the most direct approach with the greatest
likelihood for expression. To produce the recombinant suicide plasmid, molecular cloning of an
antigenic C. jejuni gene (i.e., cjaA) into the passenger region of the Baa1-encoding
autotransporter was the primary strategy. Since the Baa1 autotransporter was shown to be
involved in tracheal cell attachment and is also antigenic, this protein was a good candidate for
the heterologous vaccine platform. Apparent instability of the C. jejuni genes in the B. avium
chromosome led to the synthesis of the plasmid and simultaneous codon optimization of the cjaA
gene as a way to combat the instability. After tri-parental mating and primer design, first and
second crossovers in the process of homologous recombination were verified resulting in a
successful B. avium/ C. jejuni transconjugant.
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Multiple attempts were made to verify that the construct crossed over into the B. avium
chromosome. Various annealing temperatures, polymerases, and controls were used to detect the
construct to no avail. However, evidence that other regions of the chromosome were amplifiable
(Figure 5) led to the conclusion that this was not necessarily a matter of PCR, but rather
instability of the C. jejuni- containing construct within the B. avium chromosome. B. avium has a
GC content of 61% whereas C. jejuni has a GC content of approximately 30%. This difference
impacts translation of proteins within these two organisms and is thought to be a main reason of
the instability of the construct. Since other regions of the chromosome were amplifiable, it was
reasonable to conclude that the specific C. jejuni regions were not maintained due to instability
as a result of GC content incompatibility. In theory, synthesizing the construct would make the
cjaA region more stable when put in the B. avium chromosome.
Aside from synthesizing the construct, PCR optimization played a major role in this
project. For example, when verifying the first crossover using ProCjaTra-F/ProCjaTra-R (Figure
7) and CjaO-F/ ProCjaTra-R (Figure 8), unexpected nonspecific bands were present in the
samples, but were not in the positive control that was the synthesized plasmid. These bands may
have been showing that some primer was annealing to the wild type copy of the promoter/
transporter regions that would have still been in the chromosome after the first crossover.
In an attempt to verify that 2-13 was indeed positive for the cjaA region, multiple PCR
reactions were completed. Nonspecific bands were present (Figure 11), but there were fewer than
the first round of PCR verification for the second crossover. This gel showed bands in the
expected size range though, which was convincing evidence that a stable chimera was produced,
but more conclusive evidence would be preferable. It is still unclear as to why a clean PCR
product could not be obtained. One possibility was that the primers were not well designed and
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that they should be designed to be longer and potentially with a higher annealing temperature.
Different strategies to primer design should be tested for optimization of PCR to obtain a larger
product yield. Eventual sequencing of the chimera should be done as the most conclusive
evidence to show the cjaA construct was transferred into the chromosome. Essentially, the part of
the process proving to be the most difficult was not the mating itself, but rather the detection and
verification of the Campylobacter gene in the B. avium chromosome.
The size difference in colonies when removing kanamycin resistance was an interesting
secondary finding of this study. This morphology difference may be due in part to the expression
of the cjaA gene in B. avium. A C. jejuni gene has never been inserted into baa1 before, so
phenotypic consequences of doing so were unknown. If this insertion is unknowingly reducing
the fitness of the B. avium cell, the second crossover is more likely to regenerate the wild type
copy of the gene rather than the mutation (13). It is quite possible that the different sizes of the
colonies correspond to which copy of baa1 they contained. If the morphology was truly due to
the expression of CjaA in a B. avium cell, future expression studies can potentially elucidate why
the morphologies differed.
In this study, we continued the construction of a heterologous vaccine combatting the
causative agent of food poisoning and bordetellosis, C. jejuni and B. avium respectively. Future
work will involve the testing of the transconjugant 2-13 in a turkey tracheal cell adhesion assy.
Previous work showed that loss of Baa1 reduced B. avium adhesion to the host cell, but did not
affect infection rate in turkeys (5). It is important that this mutant version of Baa1 adheres to the
host to elicit an immune response. A preliminary study using standard methodology (10) will be
done to assess how well the cjaA-encoded protein is translocated to the surface of the bacterial
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cell. In vivo studies facilitated by partners at the VA/MD School of Veterinary Medicine (VT)
will be performed to further study the mutant. Finally, challenge studies will be performed.
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Supplemental Data
Table S1. Primers for the Synthesized Plasmid Containing the Optimized ProCjaTra Gene
Primer Name

Sequence (5’ to 3’)

Tm (°C)

ProCjaTra-F

TAGGCCTCTATGCGACGCGC

66

ProCjaTra-R

AGCAGGCGGTACTCGTAAGGC

66.47

CjaO-F

TCACCATCATCATGCGGCAGCG

66.4

CjaO-R

ATCACCACGTCGTCGGCCTTC

66.47

NewCjaJunct1-F

TCAACAGTGGCGGCACCGGTCA

68.26

NewCjaJunct1-R GGCCTTCACCTCGTCGCCGAAAT

68.12

NewCjaJunct2-F

CCCAGGGCGGAAAAATCGTGCTC

68.12

NewCjaO-R

GGAAGAACTGCTCCTGGCCCAGC

69.9
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Figure S1. Campylobacter Regions Absent in B. avium Chromosome. Gel electrophoresis
image showing colony PCR of putative transconjugants. No Campylobacter bands are shown
indicating instability in the B. avium chromosome. The arrow is indicating the proper band size
of the flaA control at 912 base pairs.

1 kb ladder

(+)F (+)C (-) F1, F2, C1, C2

Figure S2. Amplifiable KanR Gene Amplifiable in Putative Transconjugants. Though the
Campylobacter gene was not present after PCR analysis, the kanamycin resistance gene was
amplifiable via PCR on the chromosomes of the putative transconjugants. The arrow is
indicating the positive control band of the kanamycin resistance gene at just under 500 base
pairs.
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